Yingwen Dong

Yingwen Dong is currently the Global Head of Biostatistics in Rare Diseases and Rare Blood Disorders at Sanofi.12 She has over 15 years of experience in the pharmaceutical industry and holds a Ph.D. in Statistics from the University of Minnesota.24

Career Highlights

• Current Role: Global Head of Biostatistics in Rare Diseases and Rare Blood Disorders at Sanofi
• Previous Role: Deputy Global Head of Oncology Biostatistics in late phase at Sanofi13
• Experience: Over 16 years in clinical development across multiple therapeutic areas including neurology, oncology, rare diseases, and rare blood disorders1

Responsibilities and Expertise

In her current role, Yingwen Dong is responsible for:

• Providing strategic inputs into overall strategy and development programs
• Leading a team of statisticians to work cross-functionally
• Balancing technical and business acumen
• Communicating and influencing effectively2

Her research interests focus on innovative clinical trial design and its application.1

Professional Involvement

Yingwen Dong is actively involved in several professional committees:

• ICSA representative on the 2024 JSM Programming Committee
• Steering committee member for the 2024 ASA Biopharmaceutical Section Regulatory-Industry Statistical Workshop
• Elected as the 2025 industry co-chair for the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
• Served as the vice chair of the ASA Committee on Membership Retention and Recruitment in 20232

Throughout her career, Yingwen Dong has gained valuable experience in various aspects of drug development, including early and late-phase clinical trials, regulatory interactions, submissions, and project management.2